Kinjal K. Shah - Infectious Diseases

Author Information

Kinjal K. Shah is affiliated with the Department of Infectious Diseases at Sterling Hospital in Ahmedabad, India. The affiliation indicates a strong connection to clinical practice and research in infectious diseases, suggesting a focus on both the medical and scientific aspects of the field.

Research Contributions

Kinjal K. Shah has made significant contributions to the fields of oncology, immunology, and infectious diseases. Notable works include studies on the regulation of WNT/Beta-Catenin signaling, T cell receptor signaling, and resistance mechanisms in leukemia such as dexamethasone resistance. Shah has also contributed to research on the safety and efficacy of Tocilizumab for treating severe SARS-CoV-2 pneumonia and has explored conditions like SARS-CoV-2 viral sepsis with meningoencephalitis. Additionally, Shah has investigated the expanding endemicity of human melioidosis in India and explored targeted therapies for T-cell acute lymphoblastic leukemia.

Aliases

Kinjal K. Shah is also known by several aliases, including K Shah, Kinjal Shah, K. K. Shah, and Kinjal K Shah. These variations are likely used across different publications and databases.

Publication and Citation Metrics

Metric Value
Total Citation Count 5,231
H-Index 17
Total Paper Count 53

Publications:

DOI: 10.1038/s41392-021-00823-w

Year: 2021

DOI: 10.4103/ijmm.IJMM_20_291

Year: 2020

Partnered Content Networks

Relevant Topics